The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Abstract
While considerable effort has focused on developing positron emission tomography β-amyloid imaging radiotracers for the early diagnosis of Alzheimer's disease, no radiotracer is available for the non-invasive quantification of tau. In this study, we detail the characterization of (18)F-THK523 as a novel tau imaging radiotracer. In vitro binding studies demonstrated that (18)F-THK523 binds with higher affinity to a greater number of binding sites on recombinant tau (K18Δ280K) compared with β-amyloid(1-42) fibrils. Autoradiographic and histofluorescence analysis of human hippocampal serial sections with Alzheimer's disease exhibited positive THK523 binding that co-localized with immunoreactive tau pathology, but failed to highlight β-amyloid plaques. Micro-positron emission tomography analysis demonstrated significantly higher retention of (18)F-THK523 (48%; P < 0.007) in tau transgenic mice brains compared with their wild-type littermates or APP/PS1 mice. The preclinical examination of THK523 has demonstrated its high affinity and selectivity for tau pathology both in vitro and in vivo, indicating that (18)F-THK523 fulfils ligand criteria for human imaging trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365 · cited 2×
“Aggregation of b -amyloid 1–42 fibril was confirmed using thioflavin T fluorescence (LeVine, 1999).”
MethodCSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225 · cited 1×
“Futhermore, abundant neurofibrillary tangles are not observed in cognitively unimpaired individuals, in contrast to b -amyloid plaques that are present in some non-demented people (Katzman et al. , 1988; Delaere et al. , 1990; Rowe et al. , 2007, 2008).”
BackgroundImaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Self-citationPost-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · cited 2×
“Recent reports indicate that the best characterized and successful imaging agent Pittsburgh Compound-B (PiB), preferentially binds to fibrillar b-amyloid contained within cored and compact plaques (Klunk et al., 2004; Maeda et al., 2007; Ikonomovic et al., 2008) and with much lower affinity to the oligomeric forms of…”
BackgroundPike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Self-citationShoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.-C., et al. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 770
Neuropathologic changes in Alzheimer's disease.
Wenk, G. L. (2003) · PubMed · Cited by 709
Rowe, C. C., Ackerman, U., Browne, W., Mulligan, R., Pike, K. L., O'Keefe, G., Tochon-Danguy, H., Chan, G., Berlangieri, S. U., Jones, G., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70001-2 · Cited by 671
Self-citationPET radiotracers: crossing the blood–brain barrier and surviving metabolism
Pike, V. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.005 · Cited by 582
PET imaging of amyloid in Alzheimer's disease
Nordberg, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 464
Preclinical Properties of 18F-AV-45: A PET Agent for Aβ Plaques in the Brain
Choi, S. R., Golding, G., Zhuang, Z., Zhang, W., Lim, N., Hefti, F., Benedum, T. E., Kilbourn, M. R., Skovronsky, D., & Kung, H. F. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065284 · Cited by 431
Agdeppa, E. D., Kepe, V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., Cole, G. M., Small, G. W., Huang, S.-C., & Barrio, J. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-j0004.2001 · Cited by 419
Pérez, M., Valpuesta, J. M., Medina, M., Montejo de Garcini, E., & Avila, J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031183.x · Cited by 411
Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
Hampel, H., Blennow, K., Shaw, L. M., Hoessler, Y. C., Zetterberg, H., & Trojanowski, J. Q. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.010 · Cited by 389
Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G.-F., Shao, L., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2990-05.2005 · Cited by 377
Holcomb, L. A., Gordon, M. N., Jantzen, P., Hsiao, K., Duff, K., & Morgan, D. (1999) · Behavior Genetics · doi:10.1023/a:1021691918517 · Cited by 353
Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies
Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., & Klein, W. L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00592.x · Cited by 349 · cited 1×
“, 2008) that are thought to be the toxic species of b-amyloid in Alzheimer’s disease (Lambert et al., 2001; Walsh et al., 2002; Ferreira et al., 2007; Cairns et al., 2009).”
BackgroundSoluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335
Hampel, H. J., Ewers, M., Bürger, K., Annas, P., Mörtberg, A., Bogstedt, A., Frölich, L., Schröder, J., Schönknecht, P., Riepe, M. W., et al. (2009) · PubMed · Cited by 305
Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0673-07.2007 · Cited by 300 · cited 1×
“…agent Pittsburgh Compound-B (PiB), preferentially binds to fibrillar b -amyloid contained within cored and compact plaques (Klunk et al. , 2004; Maeda et al. , 2007; Ikonomovic et al. , 2008) and with much lower affinity to the oligomeric forms of b -amyloid (Maezawa et al. , 2008) that are…”
BackgroundHampel, H., Ewers, M., Bürger, K., Annas, P., Mörtberg, A., Bogstedt, A., Frölich, L., Schröder, J., Schönknecht, P., Riepe, M. W., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04606 · Cited by 295
Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals.
Dishino, D. D., Welch, M. J., Kilbourn, M. R., & Raichle, M. E. (1983) · PubMed · Cited by 282
Ng, S., Villemagne, V. L., Berlangieri, S., Lee, S.-T., Cherk, M., Gong, S. J., Ackermann, U., Saunder, T., Tochon-Danguy, H., Jones, G., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037762 · Cited by 258
Self-citationLaruelle, M. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.009 · Cited by 228
Congo red and thioflavin‐T analogs detect Aβ oligomers
Maezawa, I., Hong, H., Liu, R., Wu, C., Cheng, R. H., Kung, M., Kung, H. F., Lam, K. S., Oddo, S., LaFerla, F. M., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04972.x · Cited by 227
Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease
Wisniewski, H. M., Bancher, C., Barcikowska, M., Wen, G. Y., & Currie, J. (1989) · Acta Neuropathologica · doi:10.1007/bf00688170 · Cited by 221
Okamura, N., Suemoto, T., Furumoto, S., Suzuki, M., Shimadzu, H., Akatsu, H., Yamamoto, T., Fujiwara, H., Nemoto, M., Maruyama, M., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1738-05.2005 · Cited by 212
Self-citationBarghorn, S., Davies, P., & Mandelkow, E. (2004) · Biochemistry · doi:10.1021/bi0357006 · Cited by 209
Cairns, N. J., Ikonomovic, M. D., Benzinger, T., Storandt, M., Fagan, A. M., Shah, A. R., Reinwald, L. T., Carter, D., Felton, A., Holtzman, D. M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.279 · Cited by 205
Delaère, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., & Hauw, J.-J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90391-l · Cited by 186
Self-citationDickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00065-1 · Cited by 168 · cited 2×
“…plaques (a pathological hallmark of Alzheimer’s disease); however, tau deposits are also characteristic of a larger group of neurodegenerative diseases termed tauopathies [i.e. sporadic corticobasal degeneration, progressive supranuclear palsy, Picks disease, as well as frontotemporal…”
BackgroundIn Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies
Fodero-Tavoletti, M. T., Smith, D. P., McLean, C. A., Adlard, P. A., Barnham, K. J., Foster, L. E., Leone, L., Perez, K., Cortés, M., Culvenor, J. G., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-07.2007 · Cited by 159
Self-citationD�laere, P., Duyckaerts, C. J., Brion, J., Poulain, V., & Hauw, J. (1989) · Acta Neuropathologica · doi:10.1007/bf00687893 · Cited by 135
Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias
Fodero‐Tavoletti, M. T., Rowe, C. C., McLean, C., Leone, L., Li, Q., Masters, C. L., Cappai, R., & Villemagne, V. L. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057984 · Cited by 118
Self-citationDuyckaerts, C. J., Delaère, P., Hauw, J., Abbamondi-Pinto, A. L., Sorbi, S., Allen, I. E., Brion, J., Flament-Durand, J., Duchen, L. W., Kauss, J., et al. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90226-d · Cited by 102
Duyckaerts, C., Brion, J. P., Hauw, J. J., & Flament-Durand, J. (1987) · Acta Neuropathologica · doi:10.1007/bf00693783 · Cited by 89 · cited 1×
“Unlike b -amyloid plaque deposition, human post-mortem studies indicate that neurofibrillary tangle density correlates with neurodegeneration and cognitive impairment (Duyckaerts et al. , 1987, 1990; Delaere et al. , 1989; Arriagada et al. , 1992; Dickson, 1997; McLean et al. , 1999).”
BackgroundAddressing Alzheimers Disease Tangles: From NAP to AL-108
Gozes, I., Stewart, A. J., Morimoto, B. H., Fox, A. W., Sutherland, K., & Schmechel, D. E. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207895 · Cited by 89
Wischik, C. M., & Staff, R. T. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0046-5 · Cited by 86
von Bergen�, M., Barghorn, S., Jeganathan�, S., Mandelkow, E., & Mandelkow, E. (2006) · Neurodegenerative Diseases · doi:10.1159/000095257 · Cited by 71
Invited Article: The Alzheimer disease–frontotemporal lobar degeneration spectrum
van der Zee, J., Sleegers, K., & Broeckhoven, C. V. (2008) · Neurology · doi:10.1212/01.wnl.0000327523.52537.86 · Cited by 66
Shoghi-Jadid, K. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.1.24 · Cited by 65
Visualizing Pathology Deposits in the Living Brain of Patients with Alzheimer's Disease
Kepe, V., Huang, S., Small, G. W., Satyamurthy, N., & Barrio, J. R. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12010-8 · Cited by 49
Ganzer, S., Arlt, S., Schoder, V., Buhmann, C., Mandelkow, E., Finckh, U., Beisiegel†, U., Naber, D., & Müller‐Thomsen, T. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0017-7 · Cited by 47
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Biomarker Modeling of Alzheimer’s Disease
Jack, C. R., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.12.003 · Cited by 1,002
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760
Self-citation
Metadata
- Authors
- Fodero-Tavoletti, M. T., Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., & Villemagne, V. L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-24
- Volume
- 134
- Issue
- 4
- Pages
- 1089-1100
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2100442068
- Cited by
- 328
- References
- 50
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.